Clinical studies on chronic prostatitis and prostatitis-like syndrome. (5) Evaluation of prostatitis complicated by anal disease

1)非細菌性前立腺炎および前立腺炎様症候群における肛門疾患合併率は29.7%, 活動性病変合併率は15.4%であり, 他の泌尿器科疾患での合併率に比し有意に高い.2)合併肛門疾患では痔疾患とくに痔核の合併頻度が高い.3)治療による臨床的有効率は非細菌性前立腺炎が71.4%, 前立腺炎様症候群が58.2%であった.4)前立腺炎と痔疾患とくに痔核の合併および発症とは深い関係がある.肛門疾患を合併する前立腺炎に対して桂枝茯苓丸は有用であったWe analyzed the incidence of anal disease in patients with nonbacterial prostatitis (NBP) or with prostatitis-like syndrome (PLS), and evaluated the clinical efficacy. The complicated rate of anal disease in these patients was 29.7% (31.8% for NBP and 28.1% for PLS), and the overall incidence of active anal disease was 15.4% (16.2% for NBP and 14.8% for PLS), it yielded a significantly higher complicated rate than other urological disease (p less than 0.01). The most common type of anal disease was hemorrhoids, especially piles. The clinical cure rate for anal disease in NBP patients was 71.4%, and in PLS patients was 58.2%. The high incidence of hemorrhoids (especially piles) was in these patients by clinico-statistical observation suggests that the development of anal disease may be etiologically correlated with NBP and PLS. Furthermore, we noted that Kampo treatment (Keisibukuryogan) was useful in the treatment of prostatitis complicated by anal disease, especially when combined with anti-hemorrhoidal suppositories against active anal disease in PLS patients (p less than 0.05)